Hospitalization for severe bacterial infections in children after exposure to NSAIDs: A prospective adverse drug reaction reporting study

Clinical Drug Investigation

Volumn 30, Issue 3, 2010, Pages 179-185

  Leroy, Sandrine ^a   Marc, Elisabeth ^a   Bavoux, Françoise ^b   Tréluyer, Jean Marc ^b   Gendrel, Dominique ^a   Bréart, Gérard ^a   Pons, Gérard ^b   Chalumeau, Martin ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Cochin Saint Vincent de Paul Hospital ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; BETAMETHASONE; CORTICOSTEROID; IBUPROFEN; MORNIFLUMATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROCALCITONIN;

ARTICLE; BACTERIAL INFECTION; CHILD; CHILD HOSPITALIZATION; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; INFANT; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SKIN INFECTION; TREATMENT DURATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HOSPITALS, GENERAL; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 77249114202     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11532890-000000000-00000     Document Type: Article

References (29)

1. Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract Suppl 2003; 135: 9-12
2. Perrott DA, Piira T, Goodenough B, et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158: 521-526
3. Goldman RD, Ko K, Linett LJ, et al. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004; 38: 146-150
4. Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007; 14: 477-484
5. Neutel CI, Pless RP. Ibuprofen use in children: a benefit or a risk? Ann Epidemiol 1997; 7: 437-439
6. Ulinski T, Guigonis V, Dunan O, et al. Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr 2004; 163: 148-150
7. Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 1997; 31: 1034-1039
8. Zerr DM, Alexander ER, Duchin JS, et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783-790
9. Hamilton SM, Bayer CR, Stevens DL, et al. Muscle injury, vimentin expression, and nonsteroidal antiinflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 2008; 198: 1692-1698
10. Aronoff DM, Mulla ZD. Nonsteroidal antiinflammatory drugs and group A streptococcal infection [letter]. Emerg Infect Dis 2006; 12: 1291
11. Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11: 1062-1066
12. Lesko SM, O'Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108-1115
13. Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588-594
14. Dubos F, Hue V, Grandbastien B, et al. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol 2008; 88: 26-30
15. Ndiaye B. É tude des facteurs de risque de survenue des surinfections cutanées chez les enfants atteints de varicelle vus à l'hô pital. Institut de veille sanitaire [online]. Available from URL: http://wwwinvssantefr/publications/2008/varicelle/index html [Accessed 2009 Nov 10]
16. Bauvin I, Lacoste A, Bonamy C. Abcès rétro et parapharynge ́ s de l'enfant: à propos d'une sé rie de 31 cas [abstract]. Arch Pediatr 2006; 13: 874
17. Revol P, Gleizal A, Kraft T, et al. Brain abscess and diffuse cervico-facial cellulitis: complication after mandibular third molar extraction. Rev Stomatol Chir Maxillofac 2003; 104: 285-289
18. Audebert S, Vic P, Feuvrier Y, et al. Radiological quiz of the month. Arch Pediatr 2004; 11: 1472, 95-97
19. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434-440
20. Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008; 14: 202-209
21. Horwitz RI, Feinstein AR. The problem of 'protopathic bias' in case-control studies. AmJ Med 1980; 68: 255-258
22. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA 1995; 273: 929-933
23. Mitchell AA, Lesko SM. When a randomised controlled trial is needed to assess drug safety: the case of paediatric ibuprofen. Drug Saf 1995; 13: 15-24
24. Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954-957
25. Committee forMedical Products for Human Use. Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. European Medicines Agency 2005 [online]. Available from URL: http://www.emea.europa.eu [Accessed 2009 Nov 10]
26. Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7: 440-445
27. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
28. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977-980
29. Bensouda L, Michaud L, Jonville-Bera APJ, et al. Is the risk of upper gastrointestinal bleeding increased with NSAID used as analgesic, in children: a case crossover study. Drug Saf 2004; 27: 919-920